scholarly article | Q13442814 |
P50 | author | Pedro Rosa-Neto | Q56985526 |
P2093 | author name string | Edith Hamel | |
Brice Ongali | |||
Clotilde Lecrux | |||
Xin-Kang Tong | |||
Panayiota Papadopoulos | |||
Tahar Aboulkassim | |||
Hans Imboden | |||
Nektaria Nicolakakis | |||
P2860 | cites work | A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 |
Astrocyte control of synaptic transmission and neurovascular coupling. | Q36525563 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
losartan | Q410074 | ||
P304 | page(s) | 126-136 | |
P577 | publication date | 2014-05-05 | |
P1433 | published in | Neurobiology of Disease | Q15716606 |
P1476 | title | Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model | |
P478 | volume | 68 |
Q92946509 | ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease |
Q36270062 | Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice |
Q46265113 | Angiotensin II Causes Neuronal Damage in Stretch-Injured Neurons: Protective Effects of Losartan, an Angiotensin T1 Receptor Blocker. |
Q64084612 | Angiotensin II Receptor 1 Blockage Limits Brain Damage and Improves Functional Outcome After Brain Injury in Aged Animals Despite Age-Dependent Reduction in AT1 Expression |
Q58805051 | Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model |
Q46370959 | Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease |
Q46152975 | Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease |
Q37440125 | Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology |
Q38952233 | Binaural blood flow control by astrocytes: listening to synapses and the vasculature. |
Q47842158 | Candesartan ameliorates brain inflammation associated with Alzheimer's disease. |
Q99562311 | Candesartan could ameliorate the COVID-19 cytokine storm |
Q39012575 | Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein |
Q55054299 | Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer's disease using functional laser speckle contrast imaging. |
Q41165985 | Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure |
Q99557504 | Drug repositioning and repurposing for Alzheimer disease |
Q36933792 | Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects |
Q48873920 | Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease |
Q94553955 | Enhanced Cerebral Blood Volume under Normobaric Hyperoxia in the J20-hAPP Mouse Model of Alzheimer's Disease |
Q38781028 | Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease |
Q56100726 | Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis |
Q54444538 | Excessive Glutamate Stimulation Impairs ACE2 Activity Through ADAM17-Mediated Shedding in Cultured Cortical Neurons. |
Q26752403 | G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs |
Q46663613 | Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis. |
Q52574481 | Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease. |
Q26770783 | Investigating Human Neurovascular Coupling Using Functional Neuroimaging: A Critical Review of Dynamic Models |
Q39623328 | Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1. |
Q47775279 | Losartan reduces the immediate and sustained increases in muscle sympathetic nerve activity after hyperacute intermittent hypoxia. |
Q46423522 | Macrophages come to mind as keys to cognitive decline |
Q38781022 | Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy |
Q38816549 | Neurovascular unit alteration in somatosensory cortex and enhancement of thermal nociception induced by amphetamine involves central AT1 receptor activation. |
Q55028803 | Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice. |
Q28074637 | Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies |
Q48073057 | Remodeling the susceptibility to stress-induced depression |
Q48113034 | Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease. |
Q38262865 | Should losartan be administered following brain injury? |
Q50420410 | Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway |
Q55007046 | Targeting Renin-Angiotensin System Against Alzheimer's Disease. |
Q26768696 | The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? |
Q40559527 | The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats |
Q26781557 | Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions |
Q51762826 | Within the Brain: The Renin Angiotensin System. |
Search more.